Lori Anne Kunkel - Insider Trading & Ownership

Entity
Individual
Location
C/O Pharmacyclics, Inc., 995 East Arques Avenue, Sunnyvale, CA
Summary
The estimated net worth of Lori Anne Kunkel is at least $1.96M dollars as of July 18, 2024. Lori Anne Kunkel is the Director of CURIS INC and owns shares of CURIS INC (CRIS) stock worth about $988K. Lori Anne Kunkel is the Director of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $891K. Lori Anne Kunkel is the Director of Oric Pharmaceuticals, Inc. and owns shares of Oric Pharmaceuticals, Inc. (ORIC) stock worth about $76.9K.
All Insider Reports
All Insider Reports

Ownership of Lori Anne Kunkel

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRIS CURIS INC Director $988K Jan 31, 2022
ELVN Enliven Therapeutics, Inc. Director $891K Apr 8, 2024
ORIC Oric Pharmaceuticals, Inc. Director $76.9K Jun 12, 2024
NRIX Nurix Therapeutics, Inc. Director $0 Jul 17, 2024

Insider Transactions Reported by Lori Anne Kunkel:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.